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The long QT syndrome (LQTS) is caused either by inherited ‘channelopathies’ or by 
acquired factors, e.g. cardiac or non-cardiac drugs that hinder the process of repolarization of 
the myocytes. The most dangerous consequence of the disturbed repolarization is the 
occurrence of a polymorphic ventricular tachycardia known as torsades de pointes (TdP), 
which can deteriorate into ventricular fibrillation. Thus, the pro-arrhythmic liability of any 
drug under development must be assessed so as to avoid the occurrence of drug-induced life-
threatening arrhythmias, for example TdP, during pharmacotherapy. 
A number of hypotheses have been proposed as concerns the generation of TdP, but 
the exact mechanism of this arrhythmia is still not clear. In the most widely accepted theory, 
the mechanism of TdP initiation involves the early afterdepolarization- (EAD) induced 
ectopic beat, while the mechanism of the arrhythmia maintenance involves the reentry. 
The most commonly used animal model for the in vivo screening of drug-induced pro-
arrhythmia is the α1-adrenoceptor-stimulated anaesthetized rabbit model of the acquired long 
QT syndrome. In the model, the ability of a test agent to evoke TdP is evaluated during 
co-administration of a ‘priming’ substance, the selective α1-adrenoceptor agonist 
methoxamine or phenylephrine. The role of the α1-adrenoceptor-stimulation, which makes 
the rabbits susceptible for the development of TdP in the presence of a repolarization 
prolonging drug, is not completely understood. It may be hypothesized that reflex 
bradycardia and/or an increased ventricular stretch, which develop as a consequence of α1-
adrenoceptor-mediated peripheral vasoconstriction and increased resistance, are the critical 
sensitizing factors. However, this hypothesis has not been proven yet. Despite the frequent 
use, the α1-adrenoceptor-sensitized anaesthetized rabbit model of TdP has not been 
characterized sufficiently to date, and the mechanism of TdP genesis is not known. 
Furthermore, there is a great demand to find parameters having great predictive value for the 





 exchanger (NCX) is considered to play an important role in Ca
2+
 
handling of cardiac myocytes. In forward mode, the NCX extrudes Ca
2+
 from the cell 
and brings Na
+
 into the cytosol with a ratio of 1:3, respectively; in reverse mode it operates in 
the opposite direction. This exchange of 3 positive charges for 2 positive charges makes the 




afterdepolarizations (DADs) and dispersion of ventricular repolarization, thus NCX may 
have a role in the development of TdP. The operation of NCX may also influence the heart 
muscle contractility. The intracellular Ca
2+
 level depends on the amount of Ca
2+
 entering the 
myocyte and the amount of Ca
2+
 removed from the myocyte. The major pathway for Ca
2+
 
extrusion is the forward mode of NCX. Thus, inhibition of the NCX may influence the cardiac 
muscle contractility. 
Aims of the study 
The main aim of our investigations was to identify the endogenous contributing factors 
of drug-induced TdP. The NCX, which was thought to be one of the key factors of the genesis 
of TdP, was examined in order to determine its contribution to i) TdP development and ii) 
cardiac contractility. 
The aim of ‘in vitro α1-adrenoceptor stimulation and stretch study’ was to investigate 
whether triggered arrhythmias induced by a constant high level of left ventricular stretch are 
able to initiate TdP in the presence of functional reentries caused by dofetilide, 
which is a blocker of the rapid component of the delayed rectifier potassium current (IKr), in 
the presence or the absence of α1-adrenoceptor stimulation in isolated Langendorff-perfused 
rabbit hearts. 
The aims of the ‘in vivo dofetilide study’ were to identify endogenous factors of drug-
induced TdP and to examine the mechanism of TdP genesis in anaesthetized, α1-
adrenoceptor-stimulated rabbits. Our study investigated whether the occurrence of dofetilide-
induced TdP is predicted by the basic haemodynamics (i.e. the blood pressure and the heart 
rate), the blood gases, the frequency of the preceding arrhythmias, the repolarization-related 
parameters or the activity of the autonomic nervous system in pentobarbital anaesthetized, 
α1-adrenoceptor-stimulated rabbits. 
The potential role of the NCX in the genesis of drug-induced TdP has been 
examined in the ‘NCX arrhythmia study’. Accordingly, the effect of the inhibition of the 
NCX by a selective NCX inhibitor (SEA0400) was investigated on the occurrence of 
dofetilide-induced TdP in isolated, Langendorff-perfused, atrioventricular nodal (AV)- 
ablated rabbit hearts. Our results show that NCX inhibition with SEA0400 did not reduce the 
incidence of dofetilide-induced TdP. Since this result questions either the role of NCX in 




validating the model with drugs known to alleviate TdP in other experimental models and in 
man. Thus, the anti-arrhythmic effect of the inhibition of the L-type Ca
2+
 current (ICaL) by 
verapamil and the inhibition of the Na
+
 current (INa) by lidocaine was tested against 
dofetilide-induced TdP in isolated, Langendorff-perfused, AV-ablated rabbit hearts. 
Our objective was in the ‘NCX contractility study’ to examine the effects of 
selective NCX inhibition by SEA0400 on the cardiac muscle contractility in isolated 
Langendorff-perfused hearts in the setting of the long action potential of the rabbit and in the 
short action potential of the rat. To clarify the inhibitory effect of SEA0400 on the reverse 
and the forward modes of the NCX in the rabbit and in the rat isolated myocardial cell, INa/Ca 
was examined by patch clamp technique. NCX protein densities of the two species were 
compared to clarify whether interspecies differences in the contractile function can be 
explained by differences in NCX expression. 
METHODS 
Animals 
Female New Zealand White rabbits were used for the in vivo TdP experiments. In 
vitro Langendorff TdP experiments were performed on hearts excised from female New 
Zealand White rabbits to assess the role of stretch and the inhibition of NCX on the genesis 
of TdP. The in vitro cardiac muscle contractility experiments were carried out on male New 
Zealand White rabbits and male Sprague-Dawley rats. 
Langendorff perfusion of the isolated hearts 
The hearts were retrogradely perfused at a constant temperature of 37°C with the 
modified Krebs-Henseleit buffer solution containing (in mM) NaCl 118.5, CaCl2 2.0, 
glucose 11.1, MgSO4 0.5, NaH2PO4 1.2, NaHCO3 25 and KCl 3. In the NCX contractility 
study, Krebs-Henseleit buffer solution contained the same salts but the concentrations of 
CaCl2, MgSO4, and KCl were 2.0 mM, 1.0 mM and 4 mM, respectively. 
Assessment of the role of α1-adrenoceptor stimulation and the constant left ventricular 
stretch in the development of torsades de pointes in isolated rabbit hearts 
In the first set of experiments, to find the appropriate dofetilide concentration in terms 





dofetilide 100 nM (n=9), and control (solvent of dofetilide, n=10)] were compared. TdP 
occurred only in the 100 nM dofetilide group and it did so with an incidence which offered 
scope for the examination of additional effects that can further increase the incidence of this 
arrhythmia. This concentration was therefore chosen and used in the remainder of the study. 
In the second set of experiments, three groups of hearts (n=8 hearts in each group) 
were perfused with 100 nM dofetilide for 40 min after 15 min of initial perfusion with 
modified Krebs-Henseleit solution. In two of the three dofetilide-perfused groups of hearts, 
methoxamine at a concentration of 100 nM was added to the dofetilide-containing perfusion 
solution. In each heart, a non-elastic balloon was inserted into the left ventricle via the mitral 
valve and was connected to a pressure transducer. The intraventricular balloon was filled 
with water at a constant volume of 1.4 ml throughout the whole experiment in the group of 
hearts perfused only with dofetilide and the vehicle of methoxamine (‘dofetilide+stretch’ 
group) and in one of the groups of hearts perfused with dofetilide and methoxamine 
(‘dofetilide+methoxamine+stretch’ group). 
Individual measurements of coronary flow, left ventricle pressure and ECG 
variables were made every 5 min and 1 min before and 1 min after the introduction of drug 
perfusion. At the end of each experiment, the atria were removed from the heart and the 
ventricles were weighed. 
The assessment of predictive parameters of dofetilide-induced torsades de pointes in α1-
adrenoceptor stimulated pentobarbital anaesthetized rabbits 
30 rabbits were used for the experiments. The animals were anaesthetized 
intravenously with pentobarbital via the marginal vein of the left ear. The rabbits were 
retrospectively divided into 2 groups according to the presence or the absence of TdP, i.e. the 
animals that experienced TdP formed the ‘TdP+’ group, and the animals that did not 
experience this arrhythmia formed the ‘TdP-’ group. 
After a 10-min baseline period, α1-adrenoceptor agonist phenylephrine infusion 
was started at increasing rates (i.e. 3, 6, 9, 12, and 15 μg/kg/min for 3, 3, 3, 3, and 5 min, 
respectively). From the 27
th
 min, dofetilide (0.02 mg/kg/min
 
iv., for 30 min) was 
administered simultaneously with the background phenylephrine infusion (at a rate of 
15 μg/kg/min) until the end of the experiments. 
All the values for the QT interval were corrected for the heart rate, Tpeak-Tend 





The beat-to-beat variability of the QT intervals was determined from the manual 
measurement data on 40 consecutive QT intervals and the corresponding RR intervals in 
sinus rhythm (‘sinus variability’) and irrespectively from the presence or absence of sinus 
rhythm at the time point of the measurement (‘real beat-to-beat variability’). Baroreflex and 
spectral analysis were performed with the arterial blood pressure and the ECG signal of the 
animals in predetermined time points. 




 exchanger, INa and ICaL in the genesis of 
dofetilide-induced torsades de pointes in isolated, AV-blocked rabbit hearts 
The AV node was ablated using forceps two minutes after mounting the hearts. 
After AV ablation the hearts were allowed to beat in their own spontaneous rhythm. 
In the first set of experiments, four groups (n=8 hearts in each group) [dofetilide 
100 nM (DOF1), SEA0400 1.0 μM + dofetilide 100 nM (SEA+DOF), and control groups: 
distilled water (H2O) and dimethyl sulfoxide, solvent of dofetilide and SEA0400, (DMSO)] 
were compared. H2O control group was involved as DMSO may affect the repolarization. 
Since SEA0400 administration did not decrease the incidence of dofetilide- 
induced TdP, a second set of experiments was designed to examine whether it is possible to 
reduce dofetilide-induced TdP with other drugs in the applied model. Lidocaine and 
verapamil were chosen as test drugs as they could successfully reduce the incidence of drug-
induced TdP in other experimental models. The second set of experiments comprised three 
groups of hearts: i) 100 nM dofetilide (DOF2), ii) 30 μM lidocaine+100 nM dofetilide 
(LID+DOF), iii) 750 nM verapamil+100 nM dofetilide (VER+DOF). 
The beat-to-beat variability of the QT and RR intervals were measured as 
described above. 




 exchanger inhibition on the cardiac muscle contractility 
in isolated rat and rabbit hearts 
The contractile function of the left ventricle in isolated rabbit and rat hearts was 
measured by using a non-elastic balloon filled with water, connected to a pressure transducer. 
The balloon was inserted into the left ventricle via an incision in the left atrium and the mitral 
valve. The ventricular systolic, end-diastolic pressures and the developed pressure (i.e, the 




A control group (which received the solvent of SEA0400) and the three treated 
groups (which received the different concentrations of SEA0400: 0.1, 0.3, and 1.0 μM) were 
compared as concerns both the rabbit heart and the rat heart. Each of the groups in the rabbit 
study contained 10 hearts, and each of the four groups in the rat study contained 12 hearts. 
Each heart was set up under Krebs perfusion and the balloon was inserted into the left 
ventricle. Then, 0.1-ml increments in the rabbit heart and 0.02-ml increments in the rat heart 
were added to the balloon volume in every minute to reach the maximum developed pressure 
(a Starling curve was constructed), the final diastolic pressure not being allowed to exceed 
10 mm Hg. Then whole procedure was repeated in the presence of the test drug. 
To examine the effects of SEA0400 on the NCX current, the whole-cell 
configuration of the patch clamp technique was applied. INa/Ca was recorded by using ramp 
pulses. 
Confocal laser scanning microscopy was applied for the quantification of the NCX 
on the sarcolemmal surface of cardiac myocyte. The fluorescent images of 25 randomly 
selected rat and 25 rabbit cardiac myocytes, in each case derived from 4 animals, were 
subjected to immunofluorescent profile analysis. 
RESULTS AND DISCUSSION 
In vitro α1-adrenoceptor stimulation and stretch study 
In the first set of experiments, spontaneous TdP occurred only in the 100 nM 
dofetilide group and it did so with a relatively low incidence, which offered scope for the 
examination of additional effects that can further increase the incidence of this arrhythmia. 
In the second set of experiments, neither the sustained load-induced left ventricular 
stretch nor methoxamine nor the in combination increased the incidence of dofetilide-
provoked TdP. 
Our ‘in vitro α1-adrenoceptor stimulation and stretch study’ indicated that neither a 
sustained load-induced constant high level of left ventricular stretch nor α1-adrenoceptor 
stimulation nor their co-application, promote the generation of TdP in the setting of 
prolonged repolarization in isolated, Langendorff-perfused rabbit hearts. The roles of 
intracardiac α1-adrenoceptor stimulation and a sustained load-induced left ventricular stretch 




suggest the importance of extracardiac α1-adrenoceptor stimulation in TdP development in 
the in vivo rabbit heart. 
Predictive parameters in the ‘in vivo dofetilide study’ 
TdP and ventricular fibrillation did not occur before the dofetilide infusion. The 
incidence of all kind of arrhythmias (ventricular premature beat, bigeminy, salvo, ventricular 
tachycardia) was higher, but not significantly, in the ‘TdP+’ group before dofetilide 
administration. There was no statistical difference in the onset times of these arrhythmias. 
There was no significant difference in the blood pressure values between the two 
groups at any time point of the measurement. 
Phenylephrine reduced the heart rates and prolonged the QT intervals in both 
groups before the dofetilide infusion, but there were no differences in the heart rates and the 
QT intervals between the groups immediately before the start of the dofetilide infusions. 
Dofetilide infusion prolonged the QT and the rate-corrected QT intervals (QTc) in both 
groups, but there was no qualitative difference in the effects of the drugs on the QT and the 
QTc intervals at any time point in either group of animals. 
There was no significant difference in the Tpeak-Tend intervals between the two 
groups at any of the three time points of the measurement. Phenylephrine slightly increased 
the TWLI in the ‘TdP+’ group, but the change remained insignificant. 
Phenylephrine infusion increased strikingly all ‘real’ beat-to-beat RR and QT 
variability parameters as compared with baseline, which indicates that the drug induced large 
number of arrhythmias and electrical instability in the heart. Dofetilide administration 
quickly exaggerated the phenylephrine-induced increase in the ‘real’ beat-to-beat variability 
of the RR and QT intervals in both the ‘TdP+’ and ‘TdP-’ groups, but the dofetilide-induced 
increase in these parameters reached statistical significance only in the ‘TdP+’ group. All 
kinds of ‘real’ RR and QT variability parameters increased even further immediately before 
the occurrence of TdP in the ‘TdP+’ group. 
Significantly higher up-BRS was found in the ‘TdP+’ group than in the ‘TdP-’ 
group when only a single between-group analysis was performed using the pooled baroreflex 
sensitivity data during the phenylephrine infusion. The mid-frequency spectral power of the 
systolic arterial pressure, which is a marker of the sympathetic activity, did not differ 










, or the 
serum pH
+
 or blood gas values between the two groups at baseline, during the phenylephrine 
infusion and at the beginning of the dofetilide infusion. 
This ‘in vivo dofetilide study’ reported that dofetilide-induced TdP was not 
determined by the baseline haemodynamics, repolarization properties, autonomic status, 
blood gases or serum ion concentrations. However, those animals that subsequently 
experienced TdP had more responsive baroreflex during phenylephrine infusion before 
dofetilide administration, which implies that vagal nerve activity might contribute to TdP 
genesis. When measured in sinus rhythm, none of the repolarization-related parameters 
forecasted dofetilide-induced TdP at any stage of the experiment. However, when arrhythmic 
activity was involved in the measurement of the beat-to-beat variability of the RR and QT 
interval, the ‘real’ variability of the RR and QT intervals predicted subsequent TdP 
occurrence. The progressive increase in the ‘real’ variability of the RR and QT interval 
implies that irregularity of the ‘preceding’ non-complex ventricular arrhythmias and the 
electrical instability rose steeply during dofetilide administration, which may be a 
prerequisite for the development of complex, re-entrant arrhythmias e.g. TdP in the model. 




 exchanger, INa and ICaL in the genesis of dofetilide-
induced torsades de pointes in isolated, AV-blocked rabbit hearts 
The applied mechanical AV block decreased the average ventricular heart rate. 
The AV ablation also led to a chaotic and irregular spontaneous ventricular rhythm, and it 
strikingly increased all parameters of the beat-to-beat variability of the RR intervals. In 
addition, the AV ablation increased all QT variability parameters, which reflected a tentative 
beat-to-beat repolarization. 
In the first set of experiments, TdP occurred in the majority of the dofetilide- 
perfused hearts. NCX inhibition with SEA0400 did not reduce the incidence of dofetilide-
induced TdP and did not affect the onset time of this arrhythmia. In the second set of 
experiments, dofetilide provoked TdP in the majority of the hearts as seen in the first set of 
experiments. Lidocaine significantly decreased the incidence of dofetilide-induced TdP, 
while verapamil completely prevented the development of this arrhythmia. 
During ‘treatment period’, in the 1st set of experiments, dofetilide perfusion 
significantly increased the mean QTc intervals and the beat-to-beat variability of the QT 





interval. NCX inhibition with SEA0400 exaggerated the dofetilide-induced increase in the 
mean QTc interval and further increased some of the QT variability parameters. Further, 
SEA0400 upon dofetilide perfusion increased the beat-to beat variability of the RR interval 
similarly to QT variability parameters without affecting the mean RR interval. 
Verapamil on top of dofetilide perfusion significantly increased the mean RR 
interval i.e. decreased the ventricular heart rate as compared with that of the DOF2 group.  
The ‘NCX arrhythmia study’ revealed that NCX neither contributed to the 
initiation nor assisted the maintenance of dofetilide-induced TdP in the applied in vitro 
experimental model, in which inhibition of the INa and ICaL currents successfully antagonized 
the genesis of this arrhythmia. Neither the prolongation of the QTc interval nor the elevation 
of the beat-to-beat variability of the QT interval correlated to the occurrence of dofetilide-
induced TdP in this model. AV ablation resulted in a chaotic idioventricular rhythm, which 
might make the hearts more sensitive to the proarrhythmic activity of dofetilide in the applied 
isolated rabbit heart model. 




 exchanger inhibition on the cardiac muscle contractility 
in isolated rat and rabbit hearts 
SEA0400 suppressed both the inward and the outward INa/Ca. IC50 values of the 
 inward (forward) and the outward (reverse) currents were 243 nM and 309 nM in rabbit, and 
120 nM and 61 nM in rat myocytes, respectively. No significant difference was seen in the 
SEA0400-induced suppression of the inward and the outward INa/Ca. 
In rabbit hearts, the applied SEA0400 concentrations (0.1, 0.3 and 1.0 μM) failed 
to alter the systolic, diastolic and developed pressures as compared with the control group.  
In rat hearts, the applied SEA0400 concentrations increased the systolic pressure in 
 a concentration-dependent manner both at a constant balloon volume and during the second 
Starling curve. The developed pressure also increased in a concentration-dependent manner 
during perfusion with SEA0400 since the systolic pressure increased whereas the diastolic 
pressure remained unchanged. 
Immunohistochemistry with confocal microscopy imaging revealed similar 
scattered distributions of the NCX protein on the surface of the rabbit and the rat myocytes. 
There was no difference in the NCX protein density between the rabbit and the rat. 
This ‘NCX contractility study’ has provided evidence that the selective inhibition 




the isolated rat heart with a short action potential duration and a higher intracellular Na
+
 
concentration, but it does not exert an appreciable influence on the contractile force in the 
isolated rabbit heart with a longer action potential duration and a lower intracellular Na
+
 
concentration. These data reveal important functional interspecies differences in contractility 
as a result of NCX inhibition. Since rabbit action potential resembles more the human action 
potential than that of rat, the NCX inhibition probably does not influence the contractile force 
of human heart under physiological circumstances. However, the effect of NCX inhibition on 
cardiac contractility under pathological conditions, e.g. heart failure, needs further 
investigations. 
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